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We report a clinical case of spotted fever group rick-
ettsiosis acquired in São Paulo, Brazil. Deﬁ  nitive diagnosis 
was supported by seroconversion between acute-phase 
and convalescent-phase serum samples. Molecular analy-
sis of skin samples indicated the agent was a novel spotted 
fever group strain closely related to Rickettsia africae, R. 
parkeri, and R. sibirica.   
R
ickettsia rickettsii is the etiologic agent of Rocky 
Mountain spotted fever (RMSF). During the past 2 
decades, a clear reemergence of RMSF has been seen in 
southeastern Brazil, where ≈350 laboratory-conﬁ  rmed cas-
es (case-fatality rate ≈30%) have been reported (1). Most of 
these cases were conﬁ  rmed solely by serologic-based tech-
niques; speciﬁ  c identiﬁ  cation of the Rickettsia species was 
not achieved. However, because these cases were clinically 
and epidemiologically compatible with RMSF, the agent 
was presumed to be R. rickettsii (1).
The occurrence of R. parkeri in Brazil has been re-
stricted to ticks; human clinical infection has been reported 
in the United States, and possibly in Uruguay (1). Addi-
tionally, a few clinical cases caused by R. felis or R. typhi 
have been reported in southeastern Brazil during the 21st 
century (2,3). We report a clinical case of SFG rickettsiosis 
in a patient from southeastern Brazil. Molecular analysis of 
clinical samples showed that the patient was infected by a 
novel SFG strain.
Case Report
On May 2, 2009, a 66-year-old man was bitten by a 
tick on his lumbar region while walking on his ranch within 
an Atlantic rainforest area. Although his primary residence 
was in the urban area of Santo André within the São Paulo 
Metropolitan region (where he reported never having been 
bitten by ticks), he often visited his ranch in Barra do Una, 
a village within the Peruíbe Municipality, southern coastal 
region of the state of São Paulo (where he reported hav-
ing been bitten by ticks several times). The area is within 
a large Atlantic rainforest reserve and is <50 m above sea 
level. The patient reported no travel to additional locations 
during the previous 3 months. Ten days after the tick bite 
(May 12, 2009), the patient reported the ﬁ  rst episode of fe-
ver (≈39°C) and took acetaminophen. On May 15, 2009, he 
visited a doctor, who prescribed oral cephalexin (500 mg, 
6×/6 h). On the next day, a macular rash appeared on his 
arms and legs, associated with muscle and joint pain. Fever 
was still present (39.5°C). On May 19, 2009, the patient 
had continuing fever (39.5°C), a macular rash (without 
itch) on his arms and legs, arthralgia, and myalgia on lower 
regions of the arms and legs and hands. The patient had an 
eschar on the lumbar region (Figure 1), exactly where he 
had removed an attached tick on May 2, 2009. He admitted 
that the tick remained attached to his skin for at least 20 
hours until being removed and discarded.
Based on suspicion of rickettsial disease, blood sam-
ples were collected the same day, and doxycycline (100 
mg, 12×/12 h) was prescribed for 10 days. Three days lat-
er (May 22, 2009), the patient returned to the laboratory 
where a new blood sample was collected, and a skin biopsy 
of the eschar was aseptically performed. The patient had 
not had a fever since May 20, 2009 (1 day after initiation of 
doxycycline therapy), but still had macular rash and joint 
and muscle pain. A third blood sample was collected 13 
days later (June 4, 2009), and no clinical abnormalities 
were found.
Blood serum was tested by using an immunoﬂ  uores-
cent antibody assay with antigens from 6 Rickettsia species 
that are present in Brazil: R. rickettsii, R. parkeri, R. felis, 
R. amblyommii, R. rhipicephali, and R. bellii (4,5). Serum 
samples were tested with a goat antihuman immunoglobulin 
(Ig) G or a goat antihuman IgM ﬂ  uorescein isothiocyanate 
conjugate (Sigma Diagnostics, St. Louis, MO, USA). Pa-
tient showed seroconversion with a minimum 8× increase 
in titers of antibodies against Rickettsia spp. between the 
ﬁ  rst samples (collected during the febrile period) and the 
third blood sample (collected 16 days later) (Table).
DNA was extracted from the skin biopsy specimen by 
using the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions 
and tested by a battery of PCRs to amplify fragments of 
the rickettsial genes citrate synthase (gltA) (primers CS-
78, CS-323, CS-239, CS-1069), outer membrane protein 
(ompB) (primers 120-M59, 120–807), and ompA (primers 
Rr190.70p, Rr190.602n), as described (6). PCR products 
were puriﬁ  ed and sequenced (4). Partial sequences were 
subjected to BLAST analysis (7) to determine similarities 
to other Rickettsia species. Partial gltA sequence (1,078 
bp) showed 100% similarity to R. sibirica (RSU59734), 
99.9% to R. parkeri (EF102236), and 99.8% to R. afri-
cae strain S (RSU59735). Partial ompB sequence (740 bp) 
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parkeri strain NOD (EU567179), and 98.6% to R. park-
eri (AF123717) and R. sibirica (AF123726). Partial ompA 
sequence (463 bp) showed 99.8% similarity to R. africae 
strain S (RSU43805), 99.6% to R. africae (EU622980), 
99.1% to R. sibirica (AF179365), and 98.3% to R. parkeri 
(RPU43802).
For each rickettsial gene, partial sequences were 
aligned with the corresponding sequences of other Rickett-
sia species available in GenBank, and rooted phylogenetic 
trees were built with PAUP 4.0b10 (8) by using the maxi-
mum likelihood method with an heuristic algorithm and the 
transition model + the Γ, transversion model + Γ, and the 
general time reversible + Γ + proportion invariant model 
for gltA, ompB, and ompA, respectively, as determined by 
Model Test (9). Tree stability was assessed by bootstrap-
ping >1,000 replicates. In all trees, the sequence from the 
Brazilian patient, designated as Rickettsia sp. Atlantic rain-
forest, grouped in a cluster composed by different strains of 
R. africae, R. parkeri, and R. sibirica. This cluster was sup-
ported by high bootstrap value for ompB tree, but low for 
the ompA tree (Figure 2). Little divergence was observed 
between SFG species in the gltA tree; clusters were gener-
ally supported by low bootstrap values (data not shown). 
Partial sequences (gltA, ompB, ompA) from Rickettsia sp. 
strain Atlantic rainforest generated in this study were de-
posited into GenBank and assigned nucleotide accession 
nos. GQ855235–GQ855237, respectively.
Conclusions
We report a clinical case of SFG rickettsiosis acquired 
in an Atlantic rainforest area of the state of São Paulo, 
Brazil. Deﬁ  nitive diagnosis is supported by demonstrat-
ing a minimum 8× increase in titers between acute-phase 
and convalescent-phase serum samples, and by identiﬁ  ca-
tion of rickettsiae in an acute-phase tissue sample (eschar), 
which was conﬁ  rmed as a novel SFG strain and designated 
as Rickettsia sp. strain Atlantic rainforest. Genetic analyses 
indicated that this new strain was similar to R. africae, R. 
parkeri, and R. sibirica. The clinical proﬁ  le of the Brazilian 
patient was similar to the disease caused by these 3 rickett-
sial species in the United States (R. parkeri) and in the Old 
World (continents of Asia, Europe, and Africa [R. africae 
or R. sibirica]), that is, mild fever, muscle and joint pain, 
eschar, rash, and no deaths (10–12). We did not observe 
regional lymphadenopathy, a clinical sign usually associ-
ated with R. parkeri, R. africae, and R. sibirica (10–12) 
infection, possibly because the inoculation eschar was on 
the lumbar region of the back.
It was recently proposed that a new Rickettsia species 
should not show >99.9%, 99.2%, and 98.8% similarity for 
the gltA, ompB, and ompA genes, respectively, with the 
most homologous validated species (13). The strain detect-
ed in the Brazilian patient showed similarity values equal 
to or greater than the above threshold values for >2 genes 
of either R. africae or R. parkeri or R. sibirica. Thus, we 
cannot identify the species for Rickettsia sp. strain Atlantic 
rainforest. Notably, it has been proposed that closely re-
lated species, such as R. parkeri and R. africae, should be 
considered strains of 1 species (12). 
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May 19  May 22  Jun 4 
IgM IgG IgM IgG IgM IgG
Rickettsia rickettsii 64 64 128 256 512 512
R. parkeri <64 <64 256 256 1,024 512
R. felis <64 <64 <64 128 <64 128
R. amblyommii <64 <64 128 <64 512 512
R. rhipicephali <64 64 128 256 512 512
R. bellii 64 <64 256 128 512 512
*Ig, immunoglobulin. 
Figure 1. Inoculation eschar on the lumbar region of the back of a 
patient infected with a Rickettsia sp. from the Atlantic rainforest in 
the state of São Paulo, southeastern Brazil.Spotted Fever Group Rickettsiosis, Brazil
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Figure 2. Molecular phylogenetic analysis of Rickettsia sp. strain 
Atlantic rainforest detected in a patient from the State of São Paulo, 
Brazil. A) A total of 740 unambiguously aligned nucleotide sites of 
the rickettsial outer membrane protein (ompB) gene were subjected 
to analysis. B) A total of 463 unambiguously aligned nucleotide sites 
of the rickettsial ompA gene were subjected to analysis. Bootstrap 
values >50% are shown at the nodes. Numbers in brackets are 
GenBank accession numbers. The strain isolated in this study is 
indicated in boldface. Scale bars indicate nucleotide substitutions 
per site.
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